Global Anti-venom Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	159 Pages	TechNavio	November, 2024	INF19384543

Best Price Guarantee
Price	from $2,500
Length	159 Pages
Publisher	TechNavio
Published Date	November, 2024
SKU	INF19384543

Global Anti-venom Market 2024-2028

Anti-Venom Market 2024-2028

The anti-venom market is forecasted to grow by USD 444.7 mn during 2023-2028, accelerating at a CAGR of 7.3% during the forecast period. The report on the anti-venom market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by prevalence of venomous bites and stings, increasing awareness about anti-venoms, and rising research and development for anti-venoms.

Technavio's anti-venom market is segmented as below:

By Type

Polyvalent anti-venoms
Monovalent anti-venoms
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the unmet medical needs of anti-venom as one of the prime reasons driving the anti-venom market growth during the next few years. Also, rising strategic alliances by key vendors and increased in individual per capita incomes will lead to sizable demand in the market.

The report on the anti-venom market covers the following areas:

Anti-Venom Market sizing
Anti-Venom Market forecast
Anti-Venom Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-venom market vendors that include Bharat Serums and Vaccines Ltd., Biological E. Ltd., Boehringer Ingelheim International GmbH, CSL Ltd., Haffkine Bio Pharmaceutical Corp. Ltd., Incepta Vaccine Ltd., Merck KGaA, MicroPharm Ltd., Ophirex, Pfizer Inc., Rare Disease Therapeutics Inc., SERB Sarl, Serum Institute of India Pvt. Ltd., Silanes, and VINS Bioproducts Ltd.. Also, the anti-venom market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value Chain Analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2023; 4.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size: 5.1 Global Anti-Venom Market 2018 - 2022; Historic Market Size - Data Table on Global Anti-Venom Market 2018 - 2022 ($ million); 5.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 5.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 5.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Five Forces Analysis: 6.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 6.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 6.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 6.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 6.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 6.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 6.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Polyvalent anti-venoms - Market size and forecast 2023-2028; Chart on Polyvalent anti-venoms - Market size and forecast 2023-2028 ($ million); Data Table on Polyvalent anti-venoms - Market size and forecast 2023-2028 ($ million); Chart on Polyvalent anti-venoms - Year-over-year growth 2023-2028 (%); Data Table on Polyvalent anti-venoms - Year-over-year growth 2023-2028 (%); 7.4 Monovalent anti-venoms - Market size and forecast 2023-2028; Chart on Monovalent anti-venoms - Market size and forecast 2023-2028 ($ million); Data Table on Monovalent anti-venoms - Market size and forecast 2023-2028 ($ million); Chart on Monovalent anti-venoms - Year-over-year growth 2023-2028 (%); Data Table on Monovalent anti-venoms - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 9.12 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.13 South Korea - Market size and forecast 2023-2028; Chart on South Korea - Market size and forecast 2023-2028 ($ million); Data Table on South Korea - Market size and forecast 2023-2028 ($ million); Chart on South Korea - Year-over-year growth 2023-2028 (%); Data Table on South Korea - Year-over-year growth 2023-2028 (%); 9.14 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.15 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.16 Italy - Market size and forecast 2023-2028; Chart on Italy - Market size and forecast 2023-2028 ($ million); Data Table on Italy - Market size and forecast 2023-2028 ($ million); Chart on Italy - Year-over-year growth 2023-2028 (%); Data Table on Italy - Year-over-year growth 2023-2028 (%); 9.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Company ranking index; Company ranking index; 12.3 Market positioning of companies; Matrix on companies position and classification; 12.4 Bharat Serums and Vaccines Ltd.; Bharat Serums and Vaccines Ltd. - Overview; Bharat Serums and Vaccines Ltd. - Product / Service; Bharat Serums and Vaccines Ltd. - Key offerings; SWOT; 12.5 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 12.6 CSL Ltd.; CSL Ltd. - Overview; CSL Ltd. - Business segments; CSL Ltd. - Key news; CSL Ltd. - Key offerings; CSL Ltd. - Segment focus; SWOT; 12.7 Haffkine Bio Pharmaceutical Corp. Ltd.; Haffkine Bio Pharmaceutical Corp. Ltd. - Overview; Haffkine Bio Pharmaceutical Corp. Ltd. - Product / Service; Haffkine Bio Pharmaceutical Corp. Ltd. - Key offerings; SWOT; 12.8 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; SWOT; 12.9 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 12.10 Rare Disease Therapeutics Inc.; Rare Disease Therapeutics Inc. - Overview; Rare Disease Therapeutics Inc. - Product / Service; Rare Disease Therapeutics Inc. - Key offerings; SWOT; 12.11 SERB Sarl; SERB Sarl - Overview; SERB Sarl - Product / Service; SERB Sarl - Key offerings; SWOT; 12.12 Serum Institute of India Pvt. Ltd.; Serum Institute of India Pvt. Ltd. - Overview; Serum Institute of India Pvt. Ltd. - Product / Service; Serum Institute of India Pvt. Ltd. - Key offerings; SWOT; 12.13 VINS Bioproducts Ltd.; VINS Bioproducts Ltd. - Overview; VINS Bioproducts Ltd. - Product / Service; VINS Bioproducts Ltd. - Key offerings; SWOT
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits10: Overview on criticality of inputs and factors of differentiation; Exhibits11: Overview on factors of disruption; Exhibits12: Impact of drivers and challenges in 2023 and 2028; Exhibits13: Parent Market; Exhibits14: Data Table on - Parent Market; Exhibits15: Market characteristics analysis; Exhibits16: Value Chain Analysis; Exhibits17: Offerings of companies included in the market definition; Exhibits18: Market segments; Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits23: Historic Market Size - Data Table on Global Anti-Venom Market 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits27: Five forces analysis - Comparison between 2023 and 2028; Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits33: Chart on Market condition - Five forces 2023 and 2028; Exhibits34: Chart on Type - Market share 2023-2028 (%); Exhibits35: Data Table on Type - Market share 2023-2028 (%); Exhibits36: Chart on Comparison by Type; Exhibits37: Data Table on Comparison by Type; Exhibits38: Chart on Polyvalent anti-venoms - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Polyvalent anti-venoms - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Polyvalent anti-venoms - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Polyvalent anti-venoms - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Monovalent anti-venoms - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Monovalent anti-venoms - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Monovalent anti-venoms - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Monovalent anti-venoms - Year-over-year growth 2023-2028 (%); Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits50: Market opportunity by Type ($ million); Exhibits51: Data Table on Market opportunity by Type ($ million); Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits55: Chart on Geographic comparison; Exhibits56: Data Table on Geographic comparison; Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on South Korea - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on South Korea - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on South Korea - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on South Korea - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Italy - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on Italy - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on Italy - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Italy - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Company ranking index; Exhibits121: Matrix on companies position and classification; Exhibits122: Bharat Serums and Vaccines Ltd. - Overview; Exhibits123: Bharat Serums and Vaccines Ltd. - Product / Service; Exhibits124: Bharat Serums and Vaccines Ltd. - Key offerings; Exhibits125: SWOT; Exhibits126: Boehringer Ingelheim International GmbH - Overview; Exhibits127: Boehringer Ingelheim International GmbH - Product / Service; Exhibits128: Boehringer Ingelheim International GmbH - Key news; Exhibits129: Boehringer Ingelheim International GmbH - Key offerings; Exhibits130: SWOT; Exhibits131: CSL Ltd. - Overview; Exhibits132: CSL Ltd. - Business segments; Exhibits133: CSL Ltd. - Key news; Exhibits134: CSL Ltd. - Key offerings; Exhibits135: CSL Ltd. - Segment focus; Exhibits136: SWOT; Exhibits137: Haffkine Bio Pharmaceutical Corp. Ltd. - Overview; Exhibits138: Haffkine Bio Pharmaceutical Corp. Ltd. - Product / Service; Exhibits139: Haffkine Bio Pharmaceutical Corp. Ltd. - Key offerings; Exhibits140: SWOT; Exhibits141: Merck KGaA - Overview; Exhibits142: Merck KGaA - Business segments; Exhibits143: Merck KGaA - Key news; Exhibits144: Merck KGaA - Key offerings; Exhibits145: Merck KGaA - Segment focus; Exhibits146: SWOT; Exhibits147: Pfizer Inc. - Overview; Exhibits148: Pfizer Inc. - Product / Service; Exhibits149: Pfizer Inc. - Key news; Exhibits150: Pfizer Inc. - Key offerings; Exhibits151: SWOT; Exhibits152: Rare Disease Therapeutics Inc. - Overview; Exhibits153: Rare Disease Therapeutics Inc. - Product / Service; Exhibits154: Rare Disease Therapeutics Inc. - Key offerings; Exhibits155: SWOT; Exhibits156: SERB Sarl - Overview; Exhibits157: SERB Sarl - Product / Service; Exhibits158: SERB Sarl - Key offerings; Exhibits159: SWOT; Exhibits160: Serum Institute of India Pvt. Ltd. - Overview; Exhibits161: Serum Institute of India Pvt. Ltd. - Product / Service; Exhibits162: Serum Institute of India Pvt. Ltd. - Key offerings; Exhibits163: SWOT; Exhibits164: VINS Bioproducts Ltd. - Overview; Exhibits165: VINS Bioproducts Ltd. - Product / Service; Exhibits166: VINS Bioproducts Ltd. - Key offerings; Exhibits167: SWOT; Exhibits168: Inclusions checklist; Exhibits169: Exclusions checklist; Exhibits170: Currency conversion rates for US$; Exhibits171: Research methodology; Exhibits172: Information sources; Exhibits173: Data validation; Exhibits174: Validation techniques employed for market sizing; Exhibits175: Data synthesis; Exhibits176: 360 degree market analysis; Exhibits177: List of abbreviations